Shares of Cellcom Israel Ltd. (NYSE:CEL) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.
Zacks has also given Cellcom Israel an industry rank of 60 out of 265 based on the ratings given to its competitors.
Separately, Barclays PLC cut shares of Cellcom Israel to a “hold” rating in a report on Thursday, January 19th.
TRADEMARK VIOLATION WARNING: This piece was originally reported by sleekmoney and is owned by of sleekmoney. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://sleekmoney.com/zacks-cellcom-israel-ltd-cel-given-consensus-rating-of-strong-buy-by-brokerages/1739241.html.
Cellcom Israel (NYSE:CEL) traded down 0.61% during midday trading on Thursday, reaching $9.74. 6,571 shares of the company were exchanged. Cellcom Israel has a 52-week low of $5.70 and a 52-week high of $11.19. The company has a market capitalization of $1.14 billion, a price-to-earnings ratio of 24.05 and a beta of 2.21. The company has a 50 day moving average of $10.51 and a 200-day moving average of $9.03.
Cellcom Israel (NYSE:CEL) last released its quarterly earnings data on Wednesday, March 15th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by $0.17. Cellcom Israel had a return on equity of 12.40% and a net margin of 3.83%. On average, equities research analysts anticipate that Cellcom Israel will post $0.44 earnings per share for the current fiscal year.
Several institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. boosted its position in shares of Cellcom Israel by 5.1% in the third quarter. JPMorgan Chase & Co. now owns 713,926 shares of the company’s stock worth $5,347,000 after buying an additional 34,873 shares during the last quarter. Renaissance Technologies LLC boosted its position in shares of Cellcom Israel by 0.5% in the fourth quarter. Renaissance Technologies LLC now owns 3,693,300 shares of the company’s stock worth $29,288,000 after buying an additional 19,546 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Cellcom Israel during the fourth quarter worth approximately $15,801,000. 6.27% of the stock is currently owned by institutional investors and hedge funds.
About Cellcom Israel
Cellcom Israel Ltd. is engaged in the provision of cellular telephone services. The Company offers fixed-line services. The Company operates in two segments: Cellular and Fixed-line. The cellular segment includes the cellular communications services, end user cellular equipment and supplemental services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/zacks-cellcom-israel-ltd-cel-given-consensus-rating-of-strong-buy-by-brokerages/1739241.html
Receive News & Ratings for Cellcom Israel Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellcom Israel Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.